Myelitis due to Coccidioidomycosis in an Immunocompetent Patient

Myelitis of the spinal cord is an uncommon presentation of disseminated coccidioidomycosis. Most infected patients present subclinically, but patients, especially those who are immunocompromised, may progress to disseminated disease. We present a 50-year-old immunocompetent patient with no significa...

Full description

Saved in:
Bibliographic Details
Main Authors: Tetyana Vaysman, Sean Villaflores, Carlyn Estrella, Suman Radhakrishna, Antonio Liu
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2018/2176269
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550384724344832
author Tetyana Vaysman
Sean Villaflores
Carlyn Estrella
Suman Radhakrishna
Antonio Liu
author_facet Tetyana Vaysman
Sean Villaflores
Carlyn Estrella
Suman Radhakrishna
Antonio Liu
author_sort Tetyana Vaysman
collection DOAJ
description Myelitis of the spinal cord is an uncommon presentation of disseminated coccidioidomycosis. Most infected patients present subclinically, but patients, especially those who are immunocompromised, may progress to disseminated disease. We present a 50-year-old immunocompetent patient with no significant past medical history exhibiting symptoms of altered mental status, dizziness, headache, nausea, and quadriplegia. Upon investigation with lumbar puncture, cerebrospinal fluid (CSF) culture, and coccidioidal antibody studies, the patient was found to have acute coccidioidomycosis. Magnetic resonance imaging (MRI) of the brain demonstrated meningeal enhancements suggestive of meningitis, and further MRI study of the cervical spine revealed myelitis. Treatment with IV fluconazole for 2 weeks and IV voriconazole therapy over 3 weeks yielded limited improvement. The presentation of myelitis due to coccidioidomycosis infection is very rare and has infrequently reported in the literature. Awareness of this potentially fatal complication in immunocompetent patients can aid in faster recognition and treatment.
format Article
id doaj-art-e21adcbd7a7c425bb48c884b2da6fdd8
institution Kabale University
issn 2090-6625
2090-6633
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Infectious Diseases
spelling doaj-art-e21adcbd7a7c425bb48c884b2da6fdd82025-02-03T06:06:57ZengWileyCase Reports in Infectious Diseases2090-66252090-66332018-01-01201810.1155/2018/21762692176269Myelitis due to Coccidioidomycosis in an Immunocompetent PatientTetyana Vaysman0Sean Villaflores1Carlyn Estrella2Suman Radhakrishna3Antonio Liu4Department of Neurology and Infectious Disease, California Hospital Medical Center, Los Angeles, CA, USADepartment of Neurology and Infectious Disease, California Hospital Medical Center, Los Angeles, CA, USADepartment of Neurology and Infectious Disease, California Hospital Medical Center, Los Angeles, CA, USADepartment of Neurology and Infectious Disease, California Hospital Medical Center, Los Angeles, CA, USADepartment of Neurology and Infectious Disease, California Hospital Medical Center, Los Angeles, CA, USAMyelitis of the spinal cord is an uncommon presentation of disseminated coccidioidomycosis. Most infected patients present subclinically, but patients, especially those who are immunocompromised, may progress to disseminated disease. We present a 50-year-old immunocompetent patient with no significant past medical history exhibiting symptoms of altered mental status, dizziness, headache, nausea, and quadriplegia. Upon investigation with lumbar puncture, cerebrospinal fluid (CSF) culture, and coccidioidal antibody studies, the patient was found to have acute coccidioidomycosis. Magnetic resonance imaging (MRI) of the brain demonstrated meningeal enhancements suggestive of meningitis, and further MRI study of the cervical spine revealed myelitis. Treatment with IV fluconazole for 2 weeks and IV voriconazole therapy over 3 weeks yielded limited improvement. The presentation of myelitis due to coccidioidomycosis infection is very rare and has infrequently reported in the literature. Awareness of this potentially fatal complication in immunocompetent patients can aid in faster recognition and treatment.http://dx.doi.org/10.1155/2018/2176269
spellingShingle Tetyana Vaysman
Sean Villaflores
Carlyn Estrella
Suman Radhakrishna
Antonio Liu
Myelitis due to Coccidioidomycosis in an Immunocompetent Patient
Case Reports in Infectious Diseases
title Myelitis due to Coccidioidomycosis in an Immunocompetent Patient
title_full Myelitis due to Coccidioidomycosis in an Immunocompetent Patient
title_fullStr Myelitis due to Coccidioidomycosis in an Immunocompetent Patient
title_full_unstemmed Myelitis due to Coccidioidomycosis in an Immunocompetent Patient
title_short Myelitis due to Coccidioidomycosis in an Immunocompetent Patient
title_sort myelitis due to coccidioidomycosis in an immunocompetent patient
url http://dx.doi.org/10.1155/2018/2176269
work_keys_str_mv AT tetyanavaysman myelitisduetococcidioidomycosisinanimmunocompetentpatient
AT seanvillaflores myelitisduetococcidioidomycosisinanimmunocompetentpatient
AT carlynestrella myelitisduetococcidioidomycosisinanimmunocompetentpatient
AT sumanradhakrishna myelitisduetococcidioidomycosisinanimmunocompetentpatient
AT antonioliu myelitisduetococcidioidomycosisinanimmunocompetentpatient